M. Richardson

发表

Outcome of Simian-Human Immunodeficiency Virus Strain 89.6p Challenge following Vaccination of Rhesus Macaques with Human Immunodeficiency Virus Tat Protein

Mark G. Lewis, K. Khalili, J. Zagury, 2002, Journal of Virology.

Transdominant Activity of Human Immunodeficiency Virus Type 1 Vpr with a Mutation at Residue R73

K. Khalili, S. Amini, J. Gordon, 2000, Journal of virology.

Kruppel-like Factor 2 Modulates CCR5 Expression and Susceptibility to HIV-1 Infection

R. Doms, J. Riley, J. Jadlowsky, 2012, The Journal of Immunology.

Autoantibodies to TNFalpha in HIV-1 infection: prospects for anti-cytokine vaccine therapy.

K. Khalili, J. Zagury, J. Rappaport, 2001, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Immunogenicity of HIV-1 IIIB and SHIV 89.6P Tat and Tat toxoids in rhesus macaques: induction of humoral and cellular immune responses.

Mark G. Lewis, K. Khalili, E. Gracely, 2002, DNA and cell biology.

InfectionExpression and Susceptibility to HIV-1 Kruppel-like Factor 2 Modulates CCR5

R. Doms, J. Riley, J. Jadlowsky, 2012 .

KLF 2 Modulates CCR 5 Expression and Susceptibility to HIV-1 Infection 1

R. Doms, J. Jadlowsky, M. Richardson, 2012 .

Infection Expression and Susceptibility to HIV-1 Kruppel-like Factor 2 Modulates CCR 5

R. Doms, J. Riley, J. Jadlowsky, 2012 .

Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.

W. Blattner, A. Burny, J. Zagury, 1998, Journal of human virology.

Generation of human islet-specific regulatory T cells by TCR gene transfer.

M. Peakman, J. Maher, T. Tree, 2017, Journal of autoimmunity.

Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor

Ronald G. Collman, Michael C. Holmes, Colby R. Maldini, 2017, PLoS pathogens.

An NK-like CAR T cell transition in CAR T cell dysfunction

S. Berger, L. Lanier, C. June, 2021, Cell.

Analysis of telomere length and thymic output in fast and slow/non-progressors with HIV infection.

J. Zagury, J. Rappaport, H. Hendel, 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection.

K. Khalili, J. Zagury, J. Rappaport, 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders.

S. Croul, K. Khalili, S. Morgello, 1999, Journal of neurovirology.

Structure and function of HIV-1 and SIV Tat proteins based on carboxy-terminal truncations, chimeric Tat constructs, and NMR modeling.

K. Khalili, G. Baier‐Bitterlich, A. Tretiakova, 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

CCR5-edited CD4 T cells augment HIV-specific immunity to enable post rebound control of HIV replication.

D. Porter, B. Levine, C. June, 2021, The Journal of clinical investigation.

Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus

J. Hoxie, C. June, P. Gregory, 2016, PLoS pathogens.

Genetic engineering of T cells for adoptive immunotherapy

Michael Milone, Carl H. June, James L. Riley, 2008, Immunologic research.

CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection

S. Croul, K. Khalili, S. Morgello, 2011, Journal of NeuroVirology.

Persistent Anti-Gag, -Nef, and -Rev IgM Levels as Markers of the Impaired Functions of CD4+ T-Helper Lymphocytes During SIVmac251 Infection of Cynomolgus Macaques

K. Khalili, J. Zagury, J. Rappaport, 2005, Journal of acquired immune deficiency syndromes.

T-cell receptor excision circles (TREC) in SHIV 89.6p and SIVmac251 models of HIV-1 infection.

J. Lisziewicz, F. Lori, K. Khalili, 2004, DNA and cell biology.

Lack of immunoediting in murine pancreatic cancer reversed with neoantigen.

B. Stanger, R. A. Evans, J. Riley, 2016, JCI insight.

Stabilized human TRIM5α protects human T cells from HIV-1 infection.

Xiaolu Yang, J. Riley, Lili Guo, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Design, targeting, and initial screening of sTRSV-derived hairpin ribozymes for optimum helix 1 length and catalytic efficiency in vitro.

R. Shippy, K. Khalili, P. Klotman, 2004, Methods in molecular biology.

Mode of Transmission Affects the Sensitivity of Human Immunodeficiency Virus Type 1 to Restriction by Rhesus TRIM5α

Joseph Sodroski, Nikolay Korokhov, Guido Silvestri, 2008, Journal of Virology.

T-cell receptor excision circles (TREC) and maintenance of long-term non-progression status in HIV-1 infection.

K. Khalili, E. Gracely, J. Zagury, 2003, AIDS.

Inhibition of HIV-1 expression by HIV-2

S. Arya, P. Klotman, G. Baier‐Bitterlich, 1995, Journal of Molecular Medicine.

HIV sequence variation associated with env antisense adoptive T-cell therapy in the hNSG mouse model.

Frederic D Bushman, Scott Sherrill-Mix, Gabriela Plesa, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.